Skip to content

A prospective study on the treatment of chronic musculoskeletal pain caused by osteoporosis with Jintiange capsules

A prospective study on the treatment of chronic musculoskeletal pain caused by osteoporosis with Jintiange capsules

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054084
Enrollment
Unknown
Registered
2021-12-08
Start date
2021-12-15
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain in the musculoskeletal system caused by osteoporosis

Interventions

Group 1:Use Jintiange Capsules alone, or use Jintiange Capsules on the basis of conventional western medicine treatment
Group 2:Use Xianling Gubao capsules alone, or use Xianling Gubao capsules on the basis of conventional western medicine treatment

Sponsors

The Third Affiliated Hospital of Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with chronic musculoskeletal pain caused by osteoporosis who meet the ICD-11 criteria for chronic pain; 2. Patients with 4 <=VAS score < 7 at first visit; 3. Patients who meet the diagnostic criteria for TCM diagnosis of kidney deficiency syndrome.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

MeasureTime frame
Clinical symptom score reduction rate ;VAS score for pain;Single symptom score ;Clinical symptom score change value ;Total effective rate of clinical symptom score ;Bone mineral density ;Bone conversion markers ;Short Form health Survey (SF-12) score;

Countries

China

Contacts

Public ContactChen Weiheng

The Third Affiliated Hospital of Beijing University of Chinese Medicine

drchenweiheng@163.com+86 13511013261

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026